HomeSMMT • NASDAQ
add
Summit Therapeutics Inc
Previous close
$18.82
Day range
$16.72 - $18.91
Year range
$2.10 - $33.89
Market cap
13.16B USD
Avg Volume
2.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 58.38M | 184.88% |
Net income | -56.25M | -164.50% |
Net profit margin | — | — |
Earnings per share | -0.06 | — |
EBITDA | -58.36M | -185.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 486.90M | 144.74% |
Total assets | 502.85M | 130.16% |
Total liabilities | 64.93M | -45.48% |
Total equity | 437.92M | — |
Shares outstanding | 737.45M | — |
Price to book | 31.90 | — |
Return on assets | -34.55% | — |
Return on capital | -37.70% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -56.25M | -164.50% |
Cash from operations | -30.30M | -103.38% |
Cash from investing | -108.62M | -3,015.75% |
Cash from financing | 204.14M | 89,044.98% |
Net change in cash | 65.34M | 456.60% |
Free cash flow | -39.53M | -634.03% |
About
Founded
2003
Website
Employees
105
